Xiaoyue Bi

发表

Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment

Min Chang, Minghui Li, Lu Zhang, 2022, Frontiers in Immunology.

Pathway of Cell Death and Its Role in Virus Infection.

Minghui Li, Xiaoyue Bi, Yanjie Lin, 2022, Viral immunology.

Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma

Tao Jiang, Lu Zhang, Minghui Li, 2022, Journal of Nanobiotechnology.

Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B

Tao Jiang, Rui Song, Min Chang, 2022, Frontiers in Immunology.

Cytokine Profiles and Virological Marker Monitoring during 48 Weeks Peginterferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B.

Xiaoyue Bi, Yanjie Lin, Liu Yang, 2022, Biomedical and environmental sciences : BES.

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection

Min Chang, Minghui Li, Lu Zhang, 2022, Frontiers in Immunology.

Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B

Tao Jiang, Min Chang, Minghui Li, 2022, Frontiers in Immunology.

Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients

Tao Jiang, Min Chang, Minghui Li, 2022, Frontiers in Immunology.

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients

Tao Jiang, Minghui Li, Lu Zhang, 2022, Frontiers in Microbiology.

Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B with Nucleoside (Nucleotide) Analog-Experienced Resulting in Hepatitis B Surface Antigen Clearance: A Case Report.

Minghui Li, Yao Xie, Xiaoyue Bi, 2021, Viral immunology.

Case Report: Both Mother and Child With Chronic HBV Infection Were Clinically Cured After PEG-IFN Treatment

Y. Xie, Minghui Li, Xiaoyue Bi, 2021 .

Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection

Tao Jiang, Min Chang, Yuyong Jiang, 2023, Frontiers in Immunology.

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment

Tao Jiang, Min Chang, Ronghai Huang, 2023, Frontiers in Immunology.

A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L

Tao Jiang, Min Chang, Minghui Li, 2023, Frontiers in Immunology.

Changes of natural killer cells’ phenotype in patients with chronic hepatitis B in intermittent interferon therapy

Tao Jiang, Min Chang, Minghui Li, 2023, Frontiers in Immunology.

Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection

Tao Jiang, Minghui Li, Lu Zhang, 2022, Hepatology International.

The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection

Tao Jiang, Meiying Song, Fuchuan Wang, 2022, Frontiers in Immunology.

Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection

Tao Jiang, Fuchuan Wang, Minghui Li, 2022, Frontiers in Immunology.

Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity

Tao Jiang, Rui Song, J. Dong, 2023, Frontiers in Immunology.

Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection

Tao Jiang, Min Chang, J. Dong, 2022, Frontiers in Immunology.

Study on liver histopathology of chronic HBV infected patients with different normal ALT values

Tao Jiang, Min Chang, Minghui Li, 2022, Frontiers in Immunology.

CLINICAL CURE OF A CHRONIC HEPATITIS B PATIENT WITH NORMAL SERUM ALANINE AMINOTRANSFERASE TREATED WITH PEGYLATED INTERFERON ALFA-2A: A CASE REPORT.

Tao Jiang, Minghui Li, Xiaoyue Bi, 2022, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

Impact of in vitro fertilization‐embryo transfer on mother‐to‐infant transmission in women with chronic HBV infection

G. Wan, Minghui Li, Lu Zhang, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Application of Lab-on-Chip for Detection of Microbial Nucleic Acid in Food and Environment

Mengjiao Xu, J. Dong, Y. Xie, 2021, Frontiers in Microbiology.

Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT

Tao Jiang, G. Wan, Minghui Li, 2023, Virulence.

Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy

Tao Jiang, Min Chang, Minghui Li, 2022, Frontiers in Immunology.

Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients

G. Wan, Minghui Li, Lu Zhang, 2022, Virologica Sinica.

Advances in Metagenomics and Its Application in Environmental Microorganisms

Mengjiao Xu, Minghui Li, Lu Zhang, 2021, Frontiers in Microbiology.

Severe coagulopathy caused by cefminox sodium in a liver cirrhosis patient: a case report

Minghui Li, Shu-ling Wu, Xiaoyue Bi, 2022, Infectious Agents and Cancer.

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative

Tao Jiang, Min Chang, G. Wan, 2023, Frontiers in Immunology.

Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus

Tao Jiang, Minghui Li, Xiaoyue Bi, 2023, Gastroenterology & Endoscopy.

Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury

J. Dong, Minghui Li, Lu Zhang, 2022, Frontiers in Pharmacology.

Analysis of Clinical Characteristics and Chronic Factors of Drug-induced Liver Injury in Chronic Hepatitis B Infection: A Retrospective Study

Y. Xie, Lu Zhang, Xiaoyue Bi, 2021, Hepatitis Monthly.